SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 28, 2003
or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 0-27892
SIPEX Corporation
(Exact Name of Registrant as Specified in its Charter)
| Massachusetts (State or Other Jurisdiction of Incorporation or Organization) |
04-6135748 (I.R.S. Employer Identification No.) |
|
| 233 South Hillview Drive, Milpitas, California (Address of principal executive offices) |
95035 (Zip Code) |
(408) 934-7500
Registrants telephone number, including area code
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes x No o
There were 28,110,311 shares of the Registrants Common Stock issued and outstanding as of August 5, 2003.
FORM 10-Q
SIX MONTHS ENDED JUNE 28, 2003
INDEX
| Item | ||||||||
| Number | Page | |||||||
PART I: |
FINANCIAL INFORMATION | |||||||
Item 1 |
Financial Statements | |||||||
| Consolidated Balance Sheets at June 28, 2003 and December 31, 2002 | 3 | |||||||
| Consolidated Statements of Operations for the three and six months ended June 28, | 4 | |||||||
| 2003 and June 29, 2002 | ||||||||
| Consolidated Statements of Cash Flows for the six months ended June 28, 2003 and | 5 | |||||||
| June 29, 2002 | ||||||||
| Notes To Consolidated Financial Statements | 7 | |||||||
Item 2 |
Managements Discussion and Analysis of Financial Condition and Results of Operations | 12 | ||||||
Item 3 |
Quantitative and Qualitative Disclosure about Market Risk | 25 | ||||||
Item 4 |
Controls and Procedures | 25 | ||||||
PART II: |
OTHER INFORMATION | |||||||
Item 1 |
Legal Proceedings | 26 | ||||||
Item 2 |
Changes in Securities and Use of Proceeds | 26 | ||||||
Item 3 |
Defaults Upon Senior Securities | 27 | ||||||
Item 4 |
Submission of Matters to a Vote of Security Holders | 27 | ||||||
Item 5 |
Other Information | 27 | ||||||
Item 6 |
Exhibits and Reports on Form 8-K | 27 | ||||||
| SIGNATURES | 29 | |||||||
2
Part I: FINANCIAL INFORMATION
Item 1: Financial Statements
SIPEX CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
(Unaudited)
| June 28, 2003 | December 31, 2002 | |||||||||
ASSETS |
||||||||||
Current assets: |
||||||||||
Cash and cash equivalents |
$ | 18,644 | $ | 6,489 | ||||||
Short-term investment securities |
1,499 | 9,980 | ||||||||
Accounts receivable, less allowances of $511 and $945 at
June 28, 2003 and December 31, 2002, respectively |
9,357 | 7,278 | ||||||||
Inventories |
13,373 | 14,393 | ||||||||
Prepaid expenses and other current assets |
2,550 | 3,446 | ||||||||
Total current assets |
45,423 | 41,586 | ||||||||
Property, plant, and equipment, net |
53,469 | 56,997 | ||||||||
Other assets |
462 | 203 | ||||||||
Total assets |
$ | 99,354 | $ | 98,786 | ||||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||||
Current liabilities: |
||||||||||
Accounts payable |
$ | 8,427 | $ | 8,103 | ||||||
Accrued expenses |
4,224 | 3,570 | ||||||||
Accrued restructuring costs |
79 | 755 | ||||||||
Deferred income |
2,513 | 1,383 | ||||||||
Total current liabilities |
15,243 | 13,811 | ||||||||
Long-term debt |
21,168 | 10,455 | ||||||||
Total liabilities |
36,411 | 24,266 | ||||||||
Contingencies |
| | ||||||||
Shareholders equity: |
||||||||||
Preferred stock, $0.01 par value, 1,000 shares authorized
and no shares issued or outstanding |
| | ||||||||
Common stock, $0.01 par value, 60,000 shares authorized and
28,101 shares issued and outstanding at June 28, 2003 and
December 31, 2002, respectively |
281 | 280 | ||||||||
Additional paid-in capital |
175,727 | 175,489 | ||||||||
Accumulated deficit |
(113,038 | ) | (101,179 | ) | ||||||
Accumulated other comprehensive loss |
(27 | ) | (70 | ) | ||||||
Total shareholders equity |
62,943 | 74,520 | ||||||||
Total liabilities and shareholders equity |
$ | 99,354 | $ | 98,786 | ||||||
See accompanying notes to consolidated financial statements
3
SIPEX CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
| Three Months Ended | Six Months Ended | |||||||||||||||||
| June 28, 2003 | June 29, 2002 | June 28, 2003 | June 29, 2002 | |||||||||||||||
Net sales |
$ | 14,891 | $ | 16,988 | $ | 30,008 | $ | 33,052 | ||||||||||
Cost of sales |
12,496 | 19,231 | 27,795 | 33,420 | ||||||||||||||
Gross profit (loss) |
2,395 | (2,243 | ) | 2,213 | (368 | ) | ||||||||||||
Operating expenses: |
||||||||||||||||||
Research and development |
3,427 | 3,560 | 6,360 | 6,274 | ||||||||||||||
Marketing and selling |
1,444 | 2,206 | 3,368 | 4,472 | ||||||||||||||
General and administrative |
2,146 | 2,645 | 4,115 | 4,300 | ||||||||||||||
Restructuring and facility exit costs |
(294 | ) | | (300 | ) | | ||||||||||||
Impairment of goodwill |
| 2,984 | | 2,984 | ||||||||||||||
Total operating expenses |
6,723 | 11,395 | 13,543 | 18,030 | ||||||||||||||
Loss from operations |
(4,328 | ) | (13,638 | ) | (11,330 | ) | (18,398 | ) | ||||||||||
Other expense, net |
(226 | ) | (29 | ) | (265 | ) | (116 | ) | ||||||||||
Loss before income taxes |
(4,554 | ) | (13,667 | ) | (11,595 | ) | (18,514 | ) | ||||||||||
Income tax expense |
83 | 33,826 | 264 | 31,936 | ||||||||||||||
Net loss |
$ | (4,637 | ) | $ | (47,493 | ) | $ | (11,859 | ) | $ | (50,450 | ) | ||||||
Net loss per common share basic and diluted |
$ | (0.17 | ) | $ | (1.70 | ) | $ | (0.42 | ) | $ | (1.91 | ) | ||||||
Weighted average common shares
outstanding basic and diluted |
28,055 | 27,930 | 28,043 | 26,402 | ||||||||||||||
See accompanying notes to consolidated financial statements
4
SIPEX CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
| Six Months Ended | ||||||||||||
| June 28, 2003 | June 29, 2002 | |||||||||||
Operating activities: |
||||||||||||
Net loss |
$ | (11,859 | ) | $ | (50,450 | ) | ||||||
Adjustments to reconcile net loss to net cash used in operating
activities: |
||||||||||||
Deferred income taxes |
| 31,851 | ||||||||||
Provision for uncollectible receivables and returns and allowances |
(435 | ) | 713 | |||||||||
Fixed asset impairment loss |
238 | | ||||||||||
Amortization of debt issue costs |
4 | | ||||||||||
Stock compensation expense |
55 | | ||||||||||
Loss on fixed asset disposition |
196 | | ||||||||||
Depreciation and amortization |
3,790 | 4,219 | ||||||||||
Impairment
of goodwill |
| 2,984 | ||||||||||
Write down of excess and obsolete inventories |
318 | | ||||||||||
Amortization of discount on long-term debt |
154 | | ||||||||||
Amortization of discount on short-term investment securities |
(27 | ) | | |||||||||
Changes in current assets and liabilities: |
||||||||||||
Accounts receivable |
(1,644 | ) | (1,699 | ) | ||||||||
Inventories |
702 | (396 | ) | |||||||||
Prepaid expenses and other current assets |
896 | (31 | ) | |||||||||
Other assets |
(136 | ) | | |||||||||
Accounts payable |
324 | 4,389 | ||||||||||
Accrued expenses |
654 | 1,202 | ||||||||||
Accrued restructuring costs |
(676 | ) | | |||||||||
Deferred income |
1,130 | (173 | ) | |||||||||
Net cash used in operating activities |
(6,316 | ) | (7,391 | ) | ||||||||
Investing activities: |
||||||||||||
Purchase of short-term investment securities |
(1,492 | ) | (5,961 | ) | ||||||||
Proceeds from maturity of short-term investment securities |
10,000 | | ||||||||||
Purchase of property, plant and equipment |
(696 | ) | (2,870 | ) | ||||||||
Net cash provided by (used in) investing activities |
7,812 | (8,831 | ) | |||||||||
Financing activities: |
||||||||||||
Debt issuance costs |
(128 | ) | | |||||||||
Proceeds from issuance of common stock |
184 | 24,226 | ||||||||||
Proceeds from issuance of convertible secured note |
10,560 | |||||||||||
Payments of debt obligations |
| (7,396 | ) | |||||||||
Net cash provided by financing activities |
10,616 | 16,830 | ||||||||||
Effect of foreign currency exchange rate changes on cash and cash equivalents |
43 | (56 | ) | |||||||||
Increase in cash and cash equivalents |
12,155 | 552 | ||||||||||
Cash and cash equivalents, beginning of period |
6,489 | 4,874 | ||||||||||
Cash and cash equivalents, end of period |
$ | 18,644 | $ | 5,426 | ||||||||
5
| Six Months Ended | ||||||||||||
| June 28, 2003 | June 29, 2002 | |||||||||||
Supplemental cash flow information: |
||||||||||||
Cash paid during the period for: |
||||||||||||
Income taxes |
$ | | $ | 81 | ||||||||
Interest |
$ | 170 | $ | 12 | ||||||||
See accompanying notes to consolidated financial statements
6
SIPEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 Basis of Presentation
Unaudited Interim Financial Information
We have prepared the accompanying consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the SEC) for interim financial reporting. As used herein, Sipex, the Company, we, our and similar terms include Sipex Corporation and its wholly-owned subsidiaries, unless the context indicates otherwise. These consolidated financial statements are unaudited and, in our opinion, include all adjustments, consisting of normal recurring adjustments and accruals necessary for a fair presentation of the consolidated balance sheets, operating results and cash flows for the periods presented. Operating results for the three and six months ended June 28, 2003 are not necessarily indicative of the results that may be expected for the year ending December 31, 2003 due to cyclical and other factors. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been omitted in accordance with the rules and regulations of the SEC. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2002. Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no effect on net loss as previously reported.
Principles of Consolidation
The consolidated financial statements include the accounts of Sipex and all of its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Note 2 Effect of Recent Accounting Pronouncements
In April 2002, the FASB issued SFAS No. 145, Rescission of FASB Statements 4, 44, and 64, Amendment of FASB Statement No. 13 and Technical Corrections, effective for fiscal years beginning May 15, 2002 or later. It rescinds SFAS No. 4, Reporting Gains and Losses From Extinguishments of Debt, SFAS No. 64, Extinguishments of Debt to Satisfy Sinking-Fund Requirements, and SFAS No. 44, Accounting for Intangible Assets of Motor Carriers. This Statement also amends SFAS No. 13, Accounting for Leases, to eliminate an inconsistency between the required accounting for sale-leaseback transactions and the required accounting for certain lease modifications that have economic effects similar to sale-leaseback transactions. This Statement also amends other existing authoritative pronouncements to make various technical corrections, clarify meanings or describe their applicability under changed conditions. On January 1, 2003, the Company adopted SFAS No. 145 with no material impact on its financial position, results of operations or cash flows.
In June 2002, the FASB issued SFAS No. 146, Accounting for Costs Associated With Exit or Disposal Activities. SFAS No. 146 requires companies to recognize costs associated with exit or disposal activities when they are incurred rather than at the date of commitment to an exit or disposal plan. This Statement is effective for exit or disposal activities initiated after December 31, 2002. On January 1, 2003, the Company adopted SFAS No. 146 and there was no material impact on its financial position or results of operations. Management does not expect that SFAS 146 will have a significant impact to the Companys financial position, results of operations or cash flows.
In November 2002, the FASB issued FASB Interpretation No. 45 (FIN 45), Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others. FIN 45 requires that upon issuance of a guarantee, a guarantor must recognize a liability for the fair value of a stand-ready to perform obligation assumed under a guarantee. Additionally, a guarantor must recognize a contingent obligation to make future payments when such obligation becomes probable and estimable. FIN 45 also requires additional disclosures by a guarantor in its interim and annual financial statements about the obligations associated with
7
guarantees issued. The recognition provisions of FIN 45 are effective for any guarantees that are issued or modified after December 31, 2002. The Company does not guarantee any obligations. The adoption of this interpretation did not have a material impact on the Companys financial statements.
Note 3 Stock-Based Compensation
In December 2002, the FASB issued SFAS No. 148, Accounting for Stock-Based Compensation Transition and Disclosure an Amendment of SFAS 123. SFAS No. 148 provides additional transition guidance for those entities that elect to voluntarily adopt the provisions of SFAS No. 123, Accounting for Stock-Based Compensation. Furthermore, SFAS No. 148 mandates prominent disclosures in both interim and year-end financial statements about the fair value based method of accounting for stock-based employee compensation and the effect of the method used on reported results. SFAS No. 148 is effective for fiscal years ending after December 15, 2002. The adoption of SFAS No. 148 did not have a material effect on the Companys financial position or results of operations as the Company does not intend to adopt the fair value method of accounting for stock-based employee compensation.
The Company accounts for its stock-based employee compensation plans under the recognition and measurement principles of APB Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations. No stock based compensation cost is reflected in net loss, as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on net loss and net loss per share as if the Company had applied the fair value recognition provisions of FASB Statement No. 123, Accounting for Stock Based Compensation, as amended by SFAS No. 148, to stock-based employee compensation in each period: (in thousands, except per share data)
| 3 Months Ended | 6 Months Ended | ||||||||||||||||
| June 28, 2003 | June 29, 2002 | June 28, 2003 | June 29, 2002 | ||||||||||||||
Net loss |
$ | 4,637 | $ | 47,493 | $ | 11,859 | $ | 50,450 | |||||||||
Less: Total stock-based employee
compensation expense determined
under fair value based method for
all awards, net of related tax
effects |
4,274 | 3,582 | 8,577 | 6,011 | |||||||||||||
Pro forma net loss |
8,911 | 51,075 | 20,436 | 56,461 | |||||||||||||
Net loss per share: |
|||||||||||||||||
Basic and diluted as reported |
$ | (0.17 | ) | $ | (1.70 | ) | $ | (0.42 | ) | $ | (1.91 | ) | |||||
Basic and diluted proforma |
$ | (0.32 | ) | $ | (1.83 | ) | $ | (0.73 | ) | $ | (2.14 | ) | |||||
The fair value for each award granted was estimated at the date of grant using the Black-Scholes option-pricing model, assuming no expected dividends and the following weighted average assumptions:
| 3 Months Ended | 6 Months Ended | |||||||||||||||
| June 28, 2003 | June 29, 2002 | June 28, 2003 | June 29, 2002 | |||||||||||||
Average risk-free interest
rates |
2.1 | % | 4.0 | % | 2.3 | % | 4.0 | % | ||||||||
Average expected life (in years) |
4.0 | 6.0 | 4.0 | 6.0 | ||||||||||||
Volatility |
200 | % | 247 | % | 200 | % | 247 | % | ||||||||
Note 4 Net Loss Per Share
Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based upon the weighted average number of common and common equivalent shares outstanding assuming dilution. Common equivalent shares, consisting of outstanding stock options and warrants, are included in the per share calculations where the effect of their inclusion would be dilutive. As the Company is in a net loss position, the weighted average number of common and common equivalent shares outstanding equals the weighted average number of common and common equivalent shares assuming dilution. Antidilutive potential common shares excluded from the dilution calculation represent 8,949,000 and 5,116,000 potential common shares for the three months ended June 28, 2003 and June 29, 2002, respectively, and 8,959,000 and 5,204,000 potential common shares for the six months ended June 28, 2003 and June 29, 2002, respectively.
8